---
title: Alloy Therapeutics vs Scantox
slug_a: alloytx
slug_b: scantox
site: cro
review_signal_gate: closed
canonical_path: /compare/alloytx/scantox
---

# Alloy Therapeutics vs Scantox

Side-by-side profile data from each company listing on this directory.

## Alloy Therapeutics

- Profile: [/companies/alloytx](/companies/alloytx)

Alloy Therapeutics — Product development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.

Services: 5. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Discovery Research
- Computational & In-Silico Drug Discovery
- Protein Engineering
- In Vitro Pharmacology
- Preclinical In Vivo Studies

### Modalities

- Biologics (Monoclonal Antibodies)
- Oligonucleotide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.

## Scantox

- Profile: [/companies/scantox](/companies/scantox)

Scantox — Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity.

Services: 7. Modalities: 0. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Discovery Research
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- Specialized & Large-Animal Models
- Pathology & Histology Services

### Modalities

- Data not yet provided.

### Indications

- Neurology
- Psychiatry

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.